Human Stem Cell-Based Therapies
Development of stem cell-based therapies for Parkinson's disease
... of human fetal ventral midbrain cells into PD brains have provided a proof of concept that cell replacement therapy can be used for some PD patients, beneficial for improving their ...of human fetal ...
12
The advancement of human pluripotent stem cell derived therapies into the clinic
... variability based on patient ...terminal cell type is executed completely in vitro , consistent processes can be used throughout to ensure reproducible yield and quality of β -cells, and these parameters ...
9
Stem Cell Therapies for Hemophilia A
... primitive human HSC, no reagents exist that allow hematopoietic stem and progenitor cells from sheep to be identified or purified for transplantation ...primers based on the publicly available bovine ...
175
Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies
... in cell proliferation and differentiation, SSEA-4 expression, and ATP content, and an increase in cell size and expression of β-Gal, intracellular ROS, and ...that cell death is occurring at a higher ...
13
Conventional and novel stem cell based therapies for androgenic alopecia
... Cellular therapy The multipotent SCs in the bulge region of the HF receive sig- nals from DPCs in order to proliferate and survive. 27,28,65,84,96 It has been shown that Wnt/ β -catenin signaling is essential for the ...
9
A biomaterials approach to influence stem cell fate in injectable cell based therapies
... MSC-based cell therapies, an understanding of the fac- tors that influence the functionality of cells post injec- tion is ...as cell transplantation vehicles, saline-based cell ...
15
Conversion of human adipose-derived stem cells into functional and expandable endothelial-like cells for cell-based therapies
... Cell-based therapy is a promising approach for treat- ing a range of ischemic diseases. hADSCs have already been used in clinical trials of ischemic diseases [19, 42]; however, previously published results ...
15
Stem cell delivery of therapies for brain disorders
... The large number of preclinical trials indicated that MSC-mediated therapy show promise for cellular the- rapy. However, there are some concerns that have been expressed with the use of MSCs to deliver drugs, ...
10
Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases
... preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and ...bFGF. Cell Biol ...adipose-derived stem cells yields bioactive ...
13
Understanding nucleus pulposus cell phenotype: a prerequisite for stem cell based therapies to treat intervertebral disc degeneration.
... phenotype. Differentiated MSCs showed significant increase in expression levels of classical markers COL2A1 and ACAN as well as PAX1 and FOXF1. In addition, both types of MSCs lacked expression of at least one AC marker ...
20
Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies
... pluripotent stem cell; ESC, embryonic stem cell; HLA, human leukocyte antigen; RMP, regenerative medicine product; R&D, research and development; AMED, Japan Agency for Medical ...
12
Openness, the UK Stem Cell Bank and the delivery of cell therapies: conceptual foundations for facilitation
... is based on my doctoral research on openness and the role of the UK Stem Cell Bank (UKSCB, or Bank) in the delivery of stem cell-based therapies for use in regenerative ...
17
Stem Cell-based Therapies and FDA Regulations
... Cell therapies are injected into or administered to appropriate target sites in the ...Geron’s stem cell treatment was injected into a spinal injury site by highly trained ...
6
Orthopaedic applications of nanoparticle-based stem cell therapies
... limited therapies or ...these therapies from research to the ...of stem cells in ...with stem cells can be achieved via the process of endocytosis resulting in the internalisation of these ...
12
Stem cell therapies in MS
... Laboratory science can take many years before it identifies a potential therapy. Then, once a potential therapy is identified, each phase of clinical trial can take up to five years to complete. Although this process ...
20
Progression of Treating Alzheimer’s Disease with Stem Cell-based Therapies
... in stem cell-based ...of stem cells that can be used, proof of concept experiments using animal models and finally explore clinical trials being conducted on stem ...
9
Patient Handbook on Stem Cell Therapies
... 11. WHaT SHould I be CauTIouS abouT IF I am ConSIderIng a STem Cell THeraPy? This is not a comprehensive list but some major warning signs include: Claims based on patient testimonials. Patients want ...
8
Clinical trials for stem cell therapies
... (c-kit+) stem cells and cardiosphere derived cells, [10] the cardiomyogenic differentiation capacity was clearly more effective with the cardiac derived cells than with ...timing, cell type and dose, and ...
7
Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology
... MSCs are defi ned according to three criteria proposed by the International Society for Cellular Th erapy [15]. Abstract Growing knowledge on the biology of mesenchymal stem cells (MSCs) has provided new insights ...
6
Grafting Technologies for Use in Liver Cell Therapies of Human Hepatic Stem Cells
... specific cell populations used was a result of the previous aim, and was designed to mimic the stem cell niche, increasing the success of the cell survival, expansion, and regeneration of ...
170